Literature DB >> 35051130

Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater - United States, November-December 2021.

Amy E Kirby, Rory M Welsh, Zachary A Marsh, Alexander T Yu, Duc J Vugia, Alexandria B Boehm, Marlene K Wolfe, Bradley J White, Shannon R Matzinger, Allison Wheeler, Laura Bankers, Kevin Andresen, Cristal Salatas, Devon A Gregory, Marc C Johnson, Monica Trujillo, Sherin Kannoly, Davida S Smyth, John J Dennehy, Nicolae Sapoval, Katherine Ensor, Todd Treangen, Lauren B Stadler, Loren Hopkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35051130      PMCID: PMC8774157          DOI: 10.15585/mmwr.mm7103a5

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
The United States designated the B.1.1.529 (Omicron) variant of SARS-CoV-2 (the virus that causes COVID-19) a variant of concern on November 30, 2021, and the first U.S. Omicron COVID-19 case was reported on December 1 (). By December 18, Omicron was estimated to account for 37.9% of U.S. COVID-19 cases.* Early warning systems, such as sewage (wastewater) surveillance, can help track the spread of SARS-CoV-2 variants across communities (). The National Wastewater Surveillance System (NWSS) comprises 43 health departments funded by CDC to provide data on presence of and trends in SARS-CoV-2 infections that are independent of clinical testing. In addition to total SARS-CoV-2 testing, some health departments track SARS-CoV-2 variants by detecting variant-associated mutations in wastewater. Health departments in four states (California, Colorado, New York, and Texas) were the first wastewater surveillance programs to detect evidence of Omicron in community wastewater. This report describes the initial detections in wastewater during November 21–December 16, 2021, and the interpretative framework for these types of data. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.

California

The California Department of Public Health and academic partners use mutation-specific reverse transcription–polymerase chain reaction (RT-PCR) and sequencing to track variants in wastewater collected daily from 10 sewersheds.,** Omicron-associated mutations delHV69–70 (also seen with Alpha variant [B.1.1.7 and Q lineages]) and del143–145 were detected in samples collected November 25 and November 30, 2021, from two Northern California communities (Table). Results from these samples were available on December 2; at that time, two clinical COVID-19 cases attributed to Omicron had been identified in California, but none from these communities. By December 17, del143–145 mutations were detected at all 10 sampled sewersheds in California communities.
TABLE

Detection of mutations associated with the SARS-CoV-2 B.1.1.529 (Omicron) variant in wastewater — California, Colorado, New York City, and Houston, Texas, November 21–December 16, 2021

LocationSample dateTest methodResults
California
Sewershed A
Nov 25, 2021
Mutation-specific RT-PCRs targeting delHV69–70 and del143–145*
Both mutations detected at <1,000 genomic copies/gram wastewater solids
Sewershed B
Nov 30, 2021
Mutation-specific RT-PCRs targeting delHV69–70 and del143–145*
Both mutations detected at <1,000 genomic copies/gram wastewater solids
Dec 2, 2021
Mutation-specific RT-PCRs targeting delHV69–70 and del143–145*
Both mutations detected at <1,000 genomic copies/gram wastewater solids
Partial sequencing of S-gene using ARTIC v4 73R, 74L primers
Detected 9 bp insertion mutation in s214EPE and 3 bp N211I deletion
Sewersheds (10 sites)
Dec 17, 2021
Mutation-specific RT-PCR targeting del143–145*
Mutations detected at >4,500 genomic copies/gram wastewater solids
10 of 10 sites
Colorado
Sewersheds (21 sites)
Dec 2, 2021
SARS-CoV-2-enriched tiled amplicon sequencing
Detected 13 of 17 Omicron-associated mutations
One of 21 sites
Dec 6, 2021
SARS-CoV-2-enriched tiled amplicon sequencing
No Omicron-associated mutations detected
Zero of 21 sites
Dec 9, 2021
SARS-CoV-2-enriched tiled amplicon sequencing
Detected between four and 13 of 17 Omicron-associated mutations depending on the site
Five of 21 sites
Dec 13, 2021
SARS-CoV-2-enriched tiled amplicon sequencing
Detected between six and 14 of 17 Omicron-associated mutations, depending on the site
12 of 21 sites
Dec 16, 2021
SARS-CoV-2-enriched tiled amplicon sequencing
Detected between 12 and 14 of 17 Omicron-associated mutations, depending on the site
19 of 21 sites
New York City
Sewershed A
Nov 21, 2021
Short-read sequencing of S-gene amplicon†,§
Detected 12 Omicron-associated mutations including eight mutations unique to Omicron
Nov 28, 2021
Short-read sequencing of S-gene amplicon†,§
Detected 12 Omicron-associated mutations including eight mutations unique to Omicron
Sewershed B
Nov 28, 2021
Short-read sequencing of S-gene amplicon†,§
Detected 12 Omicron-associated mutations including eight mutations unique to Omicron
Houston, Texas
Sewersheds (39 sites)Nov 29, 2021
SARS-CoV-2-enriched tiled amplicon sequencing using ARTIC v3 primers
Detected six Omicron-associated mutations
Seven of 39 sites
Dec 6, 2021
SARS-CoV-2-enriched tiled amplicon sequencing using ARTIC v3 primers
Detected 14 Omicron-associated mutations
25 of 39 sites
Dec 13, 2021
SARS-CoV-2-enriched tiled amplicon sequencing using ARTIC v3 primersDetected 18 Omicron-associated mutations
35 of 39 sites

Abbreviation: RT-PCR = reverse transcription–polymerase chain reaction.

* https://www.protocols.io/view/quantification-of-sars-cov-2-variant-mutations-hv6-b2qmqdu6

† https://www.medrxiv.org/content/10.1101/2021.03.21.21253978v1

§ https://www.medrxiv.org/content/10.1101/2021.07.26.21261142v1

¶ https://www.medrxiv.org/content/10.1101/2021.09.08.21263279v1

Abbreviation: RT-PCR = reverse transcription–polymerase chain reaction. * https://www.protocols.io/view/quantification-of-sars-cov-2-variant-mutations-hv6-b2qmqdu6 † https://www.medrxiv.org/content/10.1101/2021.03.21.21253978v1 § https://www.medrxiv.org/content/10.1101/2021.07.26.21261142v1 ¶ https://www.medrxiv.org/content/10.1101/2021.09.08.21263279v1

Colorado

The Colorado Department of Public Health and Environment conducts biweekly SARS-CoV-2 wastewater testing at 21 sewersheds, using sequencing to track variants. Thirteen Omicron-associated mutations were detected in a sample collected on December 2, 2021. At that time, only one travel-associated Omicron case had been reported in Colorado. No Omicron-associated mutations were detected in the samples collected on December 6; however, by December 16, Omicron-associated mutations were detected at 19 of 21 sewersheds.

New York City

The New York City Department of Environmental Protection tracks variants in wastewater by sequencing weekly samples collected from 14 sewersheds,*** (). Twelve Omicron-associated mutations were detected in a sample collected on November 21. By December 4, the date the wastewater data were reported, one Omicron case had been identified in a resident of the sewershed. Samples collected on November 28 from this same sewershed and from another sewershed contained Omicron-associated mutations, as reported to the health department on December 17.

Houston, Texas

The Houston Health Department conducts weekly wastewater testing at 39 sewersheds in the city and uses sequencing to track variants. Sequencing detected six Omicron-associated mutations in samples collected on November 29 from seven sewersheds across the city. The first clinical detection of Omicron in the city was reported on December 1. The number of Omicron-positive sites, as well as the number of Omicron-associated mutations detected, increased over the subsequent 2 weeks.

Discussion

The wastewater surveillance programs in these four states were the first to detect evidence of Omicron in community wastewater. Variant tracking data from wastewater cannot confirm the presence of a specific variant because the methods used cannot determine whether all variant-defining mutations are present on a single genome. However, conditions that increase confidence in the results include detection of multiple variant-associated mutations; linked mutations (i.e., on the same sequence read), or unique mutations not shared by other known variants; RNA concentration data consistent with emergence (e.g., low initial concentrations, increasing over time); the reporting of clinical cases in the area; detections in consecutive samples or via multiple methods; and RNA concentration or sequence abundance data for multiple variant-associated mutations trending together. Limitations of variant tracking in wastewater include detections inconsistent with the current epidemiology, low quality sequence data, sporadic detections, detection of a single variant-associated mutation, and conflicting trends in concentration or abundance data for mutations associated with the same variant. Reporting times >1 week can limit the usefulness of this data. The detection of Omicron-associated mutations in community wastewater provides strong early evidence that the Omicron variant was likely present or more widely distributed in these communities than originally indicated by clinical testing alone; Omicron-associated mutations were documented during November 2021, at least a week before the first U.S. case identified via clinical testing on December 1. Variant tracking data from wastewater can be used as a complement to clinical testing for early detection of emerging variants, which can help guide decisions about allocation of clinical and public health resources, testing strategies, and public health messaging.
  3 in total

1.  SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-12-17       Impact factor: 17.586

  3 in total
  15 in total

1.  Genetic Diversity and Evolutionary Convergence of Cryptic SARS-CoV-2 Lineages Detected Via Wastewater Sequencing.

Authors:  Devon A Gregory; Monica Trujillo; Clayton Rushford; Anna Flury; Sherin Kannoly; Kaung Myat San; Dustin Lyfoung; Roger W Wiseman; Karen Bromert; Ming-Yi Zhou; Ellen Kesler; Nathan Bivens; Jay Hoskins; Chung-Ho Lin; David H O'Connor; Chris Wieberg; Jeff Wenzel; Rose S Kantor; John J Dennehy; Marc C Johnson
Journal:  medRxiv       Date:  2022-06-03

Review 2.  Surveillance of omicron variants through wastewater epidemiology: Latest developments in environmental monitoring of pandemic.

Authors:  Vatika Soni; Shilpa Paital; Pankaj Raizada; Tansir Ahamad; Aftab Aslam Parwaz Khan; Sourbh Thakur; Pardeep Singh; Chaudhery Mustansar Hussain; Swati Sharma; Ashok Kumar Nadda
Journal:  Sci Total Environ       Date:  2022-06-15       Impact factor: 10.753

3.  Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India).

Authors:  Madhvi Joshi; Manish Kumar; Vaibhav Srivastava; Dinesh Kumar; Dalip Singh Rathore; Ramesh Pandit; David W Graham; Chaitanya G Joshi
Journal:  Environ Pollut       Date:  2022-07-16       Impact factor: 9.988

Review 4.  Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity.

Authors:  Sanchita Das; Karen M Frank
Journal:  Clin Lab Med       Date:  2022-03-08       Impact factor: 2.172

5.  Invited Perspective: The Promise of Wastewater Monitoring for Infectious Disease Surveillance.

Authors:  Marlene K Wolfe
Journal:  Environ Health Perspect       Date:  2022-05-12       Impact factor: 11.035

Review 6.  Passive sampling to scale wastewater surveillance of infectious disease: Lessons learned from COVID-19.

Authors:  Aaron Bivins; Devrim Kaya; Warish Ahmed; Joe Brown; Caitlyn Butler; Justin Greaves; Raeann Leal; Kendra Maas; Gouthami Rao; Samendra Sherchan; Deborah Sills; Ryan Sinclair; Robert T Wheeler; Cresten Mansfeldt
Journal:  Sci Total Environ       Date:  2022-04-20       Impact factor: 10.753

7.  [Vaccination against COVID-19: general recommendations and special populations].

Authors:  Ulrich Seybold
Journal:  MMW Fortschr Med       Date:  2022-04

8.  Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.

Authors:  Anastasia S Lambrou; Philip Shirk; Molly K Steele; Prabasaj Paul; Clinton R Paden; Betsy Cadwell; Heather E Reese; Yutaka Aoki; Norman Hassell; Xiao-Yu Zheng; Sarah Talarico; Jessica C Chen; M Steven Oberste; Dhwani Batra; Laura K McMullan; Alison Laufer Halpin; Summer E Galloway; Duncan R MacCannell; Rebecca Kondor; John Barnes; Adam MacNeil; Benjamin J Silk; Vivien G Dugan; Heather M Scobie; David E Wentworth; Jason Caravas; Nicholas A Kovacs; Jonathan G Gerhart; Han Jia Ng; Andrew Beck; Reina Chau; Roxana Cintron; Peter W Cook; Christopher A Gulvik; Dakota Howard; Yunho Jang; Kristen Knipe; Kristine A Lacek; Kara A Moser; Adrian C Paskey; Benjamin L Rambo-Martin; Roopa R Nagilla; Adam C Retchless; Matthew W Schmerer; Sandra Seby; Samuel S Shepard; Richard A Stanton; Thomas J Stark; Anna Uehara; Yvette Unoarumhi; Meghan L Bentz; Alex Burgin; Mark Burroughs; Morgan L Davis; Matthew W Keller; Lisa M Keong; Shoshona S Le; Justin S Lee; Joseph C Madden Jr; Sarah Nobles; D. Collins Owuor; Jasmine Padilla; Mili Sheth; Malania M Wilson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-02-11       Impact factor: 17.586

Review 9.  Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.

Authors:  Giorgio Tiecco; Samuele Storti; Melania Degli Antoni; Emanuele Focà; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

10.  The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance.

Authors:  G La Rosa; M Iaconelli; C Veneri; P Mancini; G Bonanno Ferraro; D Brandtner; L Lucentini; L Bonadonna; M Rossi; M Grigioni; E Suffredini
Journal:  Sci Total Environ       Date:  2022-05-06       Impact factor: 10.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.